France uses tax to put pressure on hepatitis C drug prices

September 30, 2014 11:46 AM

34 0

PARIS (Reuters) - France will tax drugmakers whose costly hepatitis C drugs threaten to throw off course its healthcare budget, the government has said, heaping pressure on pharmaceutical companies like Gilead Sciences to cut their prices.

The Socialist government said it had designed a "progressive contribution scheme" ensuring all patients can access new and more effective treatments against the liver-destroying virus, while limiting the burden of these drugs on state finances.

Also read: Rhode Island on track for $32M budget surplus

Read more

To category page